Its announcement comes around the heels of an identical licensing arrangement presented in February to Adastra Labs, which experienced until finally now focused on crafting cannabis extracts. Adastra's license also enables it to produce and provide psilocybin and psilocin – hallucinogens more commonly often known as magic mushrooms that produce o